Lv2
168 积分 2021-10-28 加入
Emraclidine, a novel positive allosteric modulator of cholinergic M4 receptors, for the treatment of schizophrenia: a two-part, randomised, double-blind, placebo-controlled, phase 1b trial
9天前
已完结
A new cholinergic mechanism for antipsychotics: emraclidine and M4 muscarinic receptors
9天前
已完结
A GIPR antagonist conjugated to GLP-1 analogues promotes weight loss with improved metabolic parameters in preclinical and phase 1 settings
12天前
已完结
Therapeutic opportunities for the treatment of NASH with genetically validated targets
1个月前
已完结
Ulcerative colitis
1个月前
已完结
Epidemiology and Pathogenesis of Ulcerative Colitis
1个月前
已完结
An Oral Interleukin-23–Receptor Antagonist Peptide for Plaque Psoriasis
2个月前
已完结
The toxicity of dimethyl sulphoxide (DMSO) for the dog, pig, rat and rabbit
3个月前
已关闭
Tumor-agnostic drug development in dMMR/MSI-H solid tumors
3个月前
已完结
Progress in systemic therapy for advanced-stage urothelial carcinoma
3个月前
已完结
皖公网安备34019202002308
